Akouos Stock Price, News & Analysis
Company Description
Akouos (NASDAQ: AKUS) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $491.0M.
AKUS stock has gained 72.8% over the past year.
This page provides a comprehensive overview of AKUS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Akouos (AKUS) stock. Over the past 12 months, the stock has gained 72.8%. At a market capitalization of $491.0M, AKUS is classified as a small-cap stock with approximately 36.9M shares outstanding.
Latest News
Akouos has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, clinical trial, fda approval, conferences. View all AKUS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AKUS Company Profile & Sector Positioning
Akouos (AKUS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing AKUS often look at related companies in the same sector, including Atyr Pharma Inc (ATYR), Arcturus Therape (ARCT), Bicycle Therapeutics Limited (BCYC), Regenxbio (RGNX), and Nanobiotix S.A. (NBTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AKUS's relative position within its industry.